Phone Counseling Improves QOL in Cervical Cancer Survivors
Cervical cancer survivors saw improvements in self-reported quality-of-life outcomes with a psychosocial telephone counseling intervention, according to a new study.
Omacetaxine Effective for Intolerant/Resistant CML
In two phase II trials, the protein synthesis inhibitor omacetaxine offered long-term efficacy in some patients with chronic-phase and accelerated-phase CML.
RCC Drug Axitinib Could Treat TKI-Resistant CML
Researchers have shown that axitinib could be repurposed as a treatment for CML patients resistant to standard TKIs through a certain molecular mechanism.
Many Women Willing to Extend Cervical Cancer Screening Intervals
Women in routine gynecologic care expressed willingness to extend screening intervals and use cytology alone or Pap-HPV cotesting if recommended by a physician.
Inhibiting Bone Turnover Could Prevent Bone Mets in Breast Cancer
An inhibitor of osteoclast formation can stop the proliferation of dormant tumor cells that in some breast cancer survivors turn into bone metastases.
Conservative Approach to CIN 2 a Good Option in Young Women
Conservative management of cervical intraepithelial neoplasia (CIN) grade 2 is an appropriate treatment option for women aged 25 years and younger.
Surveillance Yields Excellent Long-Term Outcomes in Stage I Testicular Cancer
Active surveillance is effective and yields good outcomes in patients with clinical stage I testicular cancer who underwent orchiectomy.
RNA Test for HPV Helps Stratify Cervical Cancer Risk
A test for dangerous strains of high-risk HPV using messenger RNA was shown to be reliable and effective for cervical cancer risk stratification.
Anti-PD-1 Drug Improves Survival in NSCLC, Trial Halted
A study of nivolumab compared with docetaxel in patients with squamous cell NSCLC was stopped early after an analysis showed superiority of the study drug.